Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

US Patent 11161854 · Granted Nov 2, 2021

Estimated economic value: $152,718,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dumbbell capable of adjusting weight rapidly, and dumbbell assembly2025
Bicyclic heterocycle compounds methods of use thereof for the treatment of herpe2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Method and system for vertical gradient freeze 8 inch gallium arsenide substrate2025
SHP2 phosphatase inhibitors and methods of use thereof2025
Germanium single-crystal wafer, method for preparing germanium single-crystal wa2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025